There was substantial direct proof derived from the myeloablative environment, that CsA/MTX outperforms CsA monotherapy
A overall of 21 indirect comparisons have been available for the major result. The community of indirect comparisons is revealed in Fig. 1 (dashed strains) and the relative effects are…